Researcher
Wim Laleman
- Disciplines:Gastro-enterology and hepatology, Immunology, Paediatrics and neonatology, Nursing
Affiliations
- Hepatology (Division)
Member
From1 Oct 2002 → 30 Sep 2022
Projects
1 - 8 of 8
- Design of robotic catheter and endoscopic systems for cancer treatmentFrom16 Feb 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stratifying risk and individualizing care for patients with clinically significant portal hypertension (CSPH)From7 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Acute-on-chronic liver failure (ACLF): monocyte profiles as a predictor for progression or recovery signatures in patients.From1 Dec 2019 → 31 May 2020Funding: Private funding of national origin - undefined
- MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment responseFrom1 Jan 2019 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Deciphering the molecular pathways needed to restore monocyte dysfunction during Acute-on-chronic liver failureFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Concerted Research Project from 1994
- Characterisation of the human gut virome in patients with liver steatosis in order to identify biomarkers for diagnosis and targets for drug development.From1 Oct 2018 → 31 Oct 2023Funding: FWO Strategic Basic Research Grant
- A cell-by-cell analysis of the systemic and hepatic landscape during Acute-on-Chronic Liver Failure.From13 Sep 2018 → 18 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of microcirculatory dysfunction, the innate immune system and intestinal permeability in the early onset of acute-on-chronic liver failure.From1 Oct 2010 → 30 Sep 2015Funding: FWO fellowships
Publications
231 - 240 of 285
- Flow competition between hepatic arterial and portal venous flow during hypothermic machine perfusion preservation of porcine livers(2012)
Authors: Diethard Monbaliu, Wim Laleman, Jacques Pirenne
Pages: 119 - 131 - Artificial liver support devices as treatment option for liver failure(2012)
Authors: Frederik Nevens, Wim Laleman
Pages: 17 - 26 - A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System(2012)
Authors: Björn Meijers, Wim Laleman, Pieter Vermeersch, Frederik Nevens, Alexander Wilmer, Pieter Evenepoel
- Desulfovibrio desulfuricans Bacteremia in an Immunocompromised Host with a Liver Graft and Ulcerative Colitis(2012)
Authors: Wim Laleman, Jan Verhaegen
Pages: 199 - 201 - Paddenstoelvergiftiging: een praktische aanpak(2012)
Authors: Steven Thiessen, Chris Verslype, Ann Meulemans, Diethard Monbaliu, Wim Laleman, David Cassiman, Jacques Pirenne, Frederik Nevens
Pages: 934 - 942 - Comments on 'Early features of acute-on-chronic liver failure: a prospective cohort study' - The Authors' reply(2011)
Authors: Wim Laleman, Frederik Nevens
Pages: 1766 - 1767 - Prospective study comparing different indirect methods to measure portal pressure(2011)
Authors: Geert Maleux, Steffen Fieuws, Sam Heye, Wim Laleman, David Cassiman, Chris Verslype, Frederik Nevens
Pages: 1553 - 1558 - Acute Liver Failure Secondary to Khat (Catha edulis)-Induced Necrotic Hepatitis Requiring Liver Transplantation: Case Report(2011)
Authors: Philip Roelandt, Raymond Aerts, Diethard Monbaliu, Wim Laleman, David Cassiman, Chris Verslype, Werner Van Steenbergen, Jacques Pirenne, Alexander Wilmer, Frederik Nevens
Pages: 3493 - 3495 - JAK2 INHIBITION: A NEW POTENTIAL THERAPY FOR PORTAL HYPERTENSION IN CIRRHOSIS(2011)
Authors: Sabine Klein, Michaela Granzow, Wim Laleman, Tilman Sauerbruch, Jonel Trebicka
Pages: 945A - 945A - Liver disease in the elderly(2011)
Authors: Wim Laleman, Johan Flamaing
Pages: 226 - 232